0 CHECKOUT

PRODUCT FILTERS

REGION

10
10
10
3
1

COUNTRY

10
1
1

CATEGORIES

  • 15
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

15
16
18
24

PUBLISHED

1
1
1
24

PRODUCT TYPE

14
9
1

Search for: "Abbott Labs - Ratings Research Report "

24 Products

Abbott Labs Ratings Still on Watch Neg, Will Be Lowered to 'AA' on Close of Knoll Deal Feb 01

Abstract NEW YORK (Standard & Poor's CreditWire) Feb. 14, 2001--Standard & Poor's announced today that its triple-'A' long-term corporate credit rating for Abbott Laboratories Inc. remains on CreditWatch...

Published:  February 2001
Price: 

Rating and Forecast Report ABBOTT LABS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. The three models: Valuation Model, Forecast Model...

Published:  August 2015
Price: 

After Knoll Sale Announcement, Abbott Labs Ratings Placed on Watch Neg; BASF Ratings Affirmed Dec 00

Abstract NEW YORK (Standard & Poor's CreditWire) Dec. 15, 2000--Standard & Poor's today placed its triple-'A' corporate credit and senior unsecured debt ratings and its 'A-1'-plus short-term corporate...

Published:  December 2000
Price: 

The Neurotechnology Industry 2014 Report

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments It is the only publication to provide a comprehensive...

Published:  July 2014
Price:  From

Effective Social Media Marketing Strategies for Pharmaceutical Market

The high and rapidly increasing popularity of social media platforms such as Facebook, YouTube, and Twitter is expected to revolutionize the marketing strategies employed in the pharmaceuticals industry...

Published:  August 2010
Price:  From

Social Media, Internet of Things, and the Future of Public Health

Public health is "the science and art of preventing disease, prolonging life and promoting health through the organized efforts and informed choices of society, organizations, public and private, communities...

Published:  September 2013
Price:  From

2008 Supplement Business Report

In a time of economic uncertainty, we bring your company the business solutions it needs as analysts have compiled detailed market forecasts through 2017 “This report is a compilation of 12 years of...

Published:  June 2008
Price: 

Global Biopharma Outlook 2011

Global Pharmaceutical and Biotechnology Outlook 2011 is an extensive, yet conclusive research work that encompasses a comprehensive, historical and forward looking analysis of 80 small and large cap...

Published:  January 2011
Price:  From

Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities

In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to a new...

Published:  April 2006
Price:  From

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2012

The Puerto Rico Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

Published:  October 2012
Price: 

Optoelectronics - Global Strategic Business Report

This report analyzes the worldwide markets for Optoelectronics in Millions of US$ by the following Segments - Optical Equipment & Systems, and Optical Components. Major segments analyzed under the Optical...

Published:  July 2010
Price:  From

United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2009

BMI's United Arab Emirates Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the United Arab Emirates's pharmaceuticals and healthcare industry For...

Published:  February 2009
Price: 

A Calm Sea for Biotech Credit Ratings Apr 01

Abstract Right now, it looks like smooth sailing for credit ratings in the biotech sector of the pharmaceutical industry. In contrast to the larger pharmaceutical companies, whose product pipelines...

Published:  April 2001
Price: 

S&P Extends Deadline For Comments On "Management And Governance" Credit Factors Apr 12

Abstract WASHINGTON D.C. (Standard & Poor's) April 12, 2012Standard & Poor's Ratings Services said today that as a result of significant interest by investors and rated companies, it will extend the...

Published:  April 2012
Price: 

Industry Report Card: U.S. Health Care Jan 03

Abstract The negative tone of U.S. health care industry credit actions persisting through the last half through year-end 2002, was a contrast to more upbeat conditions earlier in the year. Still, while...

Published:  January 2003
Price: 

Industry Report Card: U.S. Corporate Health Care Jan 05

Abstract As we move into 2005, pharmaceutical company woes continue to contribute to a depressed credit mood in the corporate health care sector. Among the issues facing the industry are patent expirations,...

Published:  January 2005
Price: 

Industry Report Card: U.S. Health Care Jun 02

Abstract Relatively favorable credit-rating activity since early March primarily reflected buoyant demand and pricing for health care services. Company-specific issues for pharmaceutical firms led...

Published:  June 2002
Price: 

Industry Report Card: U.S. Corporate Health Care Sep 04

Abstract Over the next few months, unless there is a reversal of this past quarter's rating trend, 2004 may become the first year since 2000 that U.S. corporate health care downgrades exceeded upgrades....

Published:  September 2004
Price: 

Industry Report Card: U.S. Health Care Sep 02

Abstract Recent health care industry credit activity has taken on a decidedly negative tone, highlighted by actions on a number of pharmaceutical firms. There were three notable rating downgrades....

Published:  September 2002
Price: 

Industry Report Card: U.S. Healthcare Aug 03

Abstract For the rest of 2003, health care providers will continue to benefit from the increasing demand for health services from an aging U.S. population. Companies will also benefit from refinancing,...

Published:  August 2003
Price: 
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Western Union Company
  • Volvo Car Corporation
  • Morgan Stanley
  • SAP SE
  • LG Corporation
  • Roche Diagnostics Ltd.